Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $12000.0.

  • Nephros' Depreciation & Amortization (CF) changed 0.0% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $54000.0, marking a year-over-year increase of 2272.73%. This contributed to the annual value of $46000.0 for FY2024, which is 1794.87% up from last year.
  • According to the latest figures from Q3 2025, Nephros' Depreciation & Amortization (CF) is $12000.0, which was down 0.0% from $13000.0 recorded in Q2 2025.
  • Nephros' 5-year Depreciation & Amortization (CF) high stood at $17000.0 for Q1 2022, and its period low was $1000.0 during Q2 2023.
  • Its 5-year average for Depreciation & Amortization (CF) is $10052.6, with a median of $11000.0 in 2022.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 9166.67% in 2023, then skyrocketed by 110000.0% in 2024.
  • Nephros' Depreciation & Amortization (CF) (Quarter) stood at $16000.0 in 2021, then crashed by 31.25% to $11000.0 in 2022, then dropped by 9.09% to $10000.0 in 2023, then rose by 20.0% to $12000.0 in 2024, then changed by 0.0% to $12000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $12000.0 in Q3 2025, compared to $13000.0 in Q2 2025 and $17000.0 in Q1 2025.